2033 Q4 Form 10-Q Financial Statement

#000141057823002231 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2033 Q4 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $671.7K
YoY Change 29.6%
% of Gross Profit
Research & Development $105.5K
YoY Change 10.44%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $781.0K
YoY Change 26.5%
Operating Profit
YoY Change
Interest Expense $70.61K
YoY Change -77.71%
% of Operating Profit
Other Income/Expense, Net $70.61K
YoY Change -78.08%
Pretax Income -$710.4K
YoY Change 140.58%
Income Tax
% Of Pretax Income
Net Earnings -$710.4K
YoY Change 140.58%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 195.9M 195.9M
Diluted Shares Outstanding 195.9M

Balance Sheet

Concept 2033 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.354M
YoY Change -56.98%
Cash & Equivalents $2.354M
Short-Term Investments
Other Short-Term Assets $200.3K
YoY Change 19.95%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.555M
YoY Change -54.7%
LONG-TERM ASSETS
Property, Plant & Equipment $7.465K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $55.38M
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $2.555M
Total Long-Term Assets $55.38M
Total Assets $57.94M
YoY Change -5.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.754K
YoY Change -56.57%
Accrued Expenses $154.9K
YoY Change -1.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $164.7K
YoY Change -8.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $164.7K
Total Long-Term Liabilities $0.00
Total Liabilities $164.7K
YoY Change -8.3%
SHAREHOLDERS EQUITY
Retained Earnings -$268.8M
YoY Change 1.32%
Common Stock $325.1M
YoY Change 0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $57.77M
YoY Change
Total Liabilities & Shareholders Equity $57.94M
YoY Change -5.06%

Cashflow Statement

Concept 2033 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$710.4K
YoY Change 140.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$534.9K
YoY Change 221.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.66K
YoY Change
NET CHANGE
Cash From Operating Activities -534.9K
Cash From Investing Activities
Cash From Financing Activities -50.66K
Net Change In Cash -585.6K
YoY Change 252.32%
FREE CASH FLOW
Cash From Operating Activities -$534.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001134115
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195313184
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195885531
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195313184
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195885531
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33638
dei Entity Registrant Name
EntityRegistrantName
INTERNATIONAL TOWER HILL MINES LTD
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0668474
dei Entity Address Address Line1
EntityAddressAddressLine1
2710 - 200 Granville Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 1S4
dei City Area Code
CityAreaCode
604
dei Local Phone Number
LocalPhoneNumber
683-6332
dei Security12b Title
Security12bTitle
Common Shares, no par value
dei Trading Symbol
TradingSymbol
THM
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2033Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
195885531
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2354317
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4847429
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
200250
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
152572
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2554567
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5000001
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
154897
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2023Q3 us-gaap Assets
Assets
57937156
CY2022Q4 us-gaap Assets
Assets
60382590
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9754
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
53539
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
234846
CY2023Q3 us-gaap Liabilities
Liabilities
164651
CY2022Q4 us-gaap Liabilities
Liabilities
288385
CY2023Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195313184
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195885531
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
288815478
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
288484901
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36296039
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36275917
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1509582
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1500196
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-268848594
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266166809
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
57772505
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
60094205
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57937156
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60382590
CY2023Q3 thm Consulting Fees
ConsultingFees
131287
CY2022Q3 thm Consulting Fees
ConsultingFees
57691
thm Consulting Fees
ConsultingFees
507536
thm Consulting Fees
ConsultingFees
490456
CY2023Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
53533
CY2022Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
51505
us-gaap General Insurance Expense
GeneralInsuranceExpense
156100
us-gaap General Insurance Expense
GeneralInsuranceExpense
152441
CY2023Q3 thm Investor Relations Expenses
InvestorRelationsExpenses
8737
CY2022Q3 thm Investor Relations Expenses
InvestorRelationsExpenses
7929
thm Investor Relations Expenses
InvestorRelationsExpenses
43548
thm Investor Relations Expenses
InvestorRelationsExpenses
57502
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
105479
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
95511
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
893122
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
860549
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13318
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5560
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22205
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15996
CY2023Q3 us-gaap Other Expenses
OtherExpenses
3795
CY2022Q3 us-gaap Other Expenses
OtherExpenses
3555
us-gaap Other Expenses
OtherExpenses
10818
us-gaap Other Expenses
OtherExpenses
11357
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
104196
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
72236
us-gaap Professional Fees
ProfessionalFees
232077
us-gaap Professional Fees
ProfessionalFees
181729
CY2023Q3 thm Regulatory Expenses
RegulatoryExpenses
71940
CY2022Q3 thm Regulatory Expenses
RegulatoryExpenses
49946
thm Regulatory Expenses
RegulatoryExpenses
158116
thm Regulatory Expenses
RegulatoryExpenses
148631
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
33796
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
33917
us-gaap Operating Lease Expense
OperatingLeaseExpense
101388
us-gaap Operating Lease Expense
OperatingLeaseExpense
101522
CY2023Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
27616
CY2022Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
16070
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
41490
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
24227
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
227261
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
223427
us-gaap Labor And Related Expense
LaborAndRelatedExpense
591677
us-gaap Labor And Related Expense
LaborAndRelatedExpense
608360
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
780958
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
617347
us-gaap Operating Expenses
OperatingExpenses
2758077
us-gaap Operating Expenses
OperatingExpenses
2652770
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
46691
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
315283
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-13925
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
410693
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
23916
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1512
us-gaap Investment Income Interest
InvestmentIncomeInterest
79737
us-gaap Investment Income Interest
InvestmentIncomeInterest
4621
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5292
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10480
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27944
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
70607
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
322087
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
76292
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
443258
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-710351
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-295260
us-gaap Net Income Loss
NetIncomeLoss
-2681785
us-gaap Net Income Loss
NetIncomeLoss
-2209512
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-50484
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-327012
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
9386
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-390982
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-50484
CY2022Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-327012
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
9386
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-390982
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-760835
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-622272
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2672399
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2600494
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195885531
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195885531
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195313184
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195313184
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195524931
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195524931
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195129206
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195129206
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
60094205
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
77556
thm Adjustments To Additional Paid In Capital Share Based Compensation Deferred Share Unit Plan
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationDeferredShareUnitPlan
323804
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
9386
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
50661
us-gaap Net Income Loss
NetIncomeLoss
-2681785
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
57772505
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
58503708
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14042
CY2023Q3 thm Adjustments To Additional Paid In Capital Share Based Compensation Deferred Share Unit Plan
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationDeferredShareUnitPlan
66251
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-50484
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
50661
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-710351
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
57772505
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
62725059
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114811
thm Adjustments To Additional Paid In Capital Share Based Compensation Deferred Share Unit Plan
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationDeferredShareUnitPlan
313023
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-390982
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
290290
us-gaap Net Income Loss
NetIncomeLoss
-2209512
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
60842689
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
61443492
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21469
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-327012
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-295260
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
60842689
us-gaap Profit Loss
ProfitLoss
-2681785
us-gaap Profit Loss
ProfitLoss
-2209512
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
77556
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
114811
thm Deferred Stock Or Unit Expense
DeferredStockOrUnitExpense
323804
thm Deferred Stock Or Unit Expense
DeferredStockOrUnitExpense
313023
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28728
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2717
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
18771
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
34387
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-123884
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-395529
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2451808
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2208877
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
290290
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
50661
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50661
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
290290
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9357
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-389380
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2493112
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2307967
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4847429
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7780671
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2354317
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5472704
thm Contributed Surplus From Issuance Of Stock
ContributedSurplusFromIssuanceOfStock
381238
thm Contributed Surplus From Issuance Of Stock
ContributedSurplusFromIssuanceOfStock
0
thm Contributed Surplus From Exercise Of Stock Options
ContributedSurplusFromExerciseOfStockOptions
0
thm Contributed Surplus From Exercise Of Stock Options
ContributedSurplusFromExerciseOfStockOptions
162479
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">1.    GENERAL INFORMATION, NATURE OF OPERATIONS AND GOING CONCERN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">International Tower Hill Mines Ltd. (“ITH” or the “Company”) is incorporated under the laws of British Columbia, Canada. The Company’s head office address is 2710 - 200 Granville Street, Vancouver, British Columbia, Canada.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">International Tower Hill Mines Ltd. consists of ITH and its wholly-owned subsidiaries Tower Hill Mines, Inc. (“TH Alaska”) (an Alaska corporation), Tower Hill Mines (US) LLC (“TH US”) (a Colorado limited liability company), and Livengood Placers, Inc. (“LPI”) (a Nevada corporation). The Company is in the business of acquiring, exploring and evaluating mineral properties, and either joint venturing or developing these properties further or disposing of them when the evaluation is completed. At <span style="background:#ffffff;">September 30, 2023</span>, the Company has a 100% interest in its Livengood Gold Project in Alaska, U.S.A (the “Livengood Gold Project”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">These unaudited condensed consolidated interim financial statements have been prepared on a going-concern basis, which presumes the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">As at <span style="background:#ffffff;">September 30, 2023</span>, the Company had cash and cash equivalents of $2,354,317 compared to $4,847,429 at December 31, 2022. The Company has no revenue generating operations from which it can internally generate funds.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">The Company will require significant additional financing to continue its operations (including general and administrative expenses) in connection with advancing activities at the Livengood Gold Project and the development of any mine that may be built at the Livengood Gold Project. There is no assurance that the Company will make a decision to build a mine at the Livengood Gold Project and, if so, that it will be able to obtain the additional financing required on acceptable terms, if at all. In addition, any significant delays in the issuance of required permits for the ongoing work at the Livengood Gold Project, or unexpected results in connection with the ongoing work, could result in the Company being required to raise additional funds to advance permitting efforts. The Company’s review of its financing options includes considering a future strategic alliance to assist in further development, permitting and future construction costs, although there can be no assurance that any such strategic alliance will, in fact, be pursued or realized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;">Despite the Company’s success to date in raising significant equity financing to fund its operations, there is significant uncertainty that the Company will be able to secure any additional financing in the current or future equity markets. Even if the Company is able to secure some additional equity financing, the Company may be unable to raise enough capital to continue its operations in connection with advancing all activities at the Livengood Gold Project into 2024 and beyond. As a result, there is substantial doubt about its ability to continue as a going concern. The amount of funds to be raised and the terms of any proposed equity financing that may be undertaken will be negotiated by management as opportunities to raise funds arise. Specific plans related to the use of proceeds will be devised once financing has been completed and management knows what funds will be available for these purposes. Due to this uncertainty, if the Company is unable to secure sufficient additional financing, the Company may be required to reduce all discretionary activities at the Project to preserve its working capital to fund anticipated non-discretionary expenditures beyond the 2024 fiscal year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;">These financial statements do not reflect the adjustments to the carrying values of assets and liabilities and the reported expenses and balance sheet classifications that would be necessary were the going concern adjustment appropriate.  Such adjustments could be material.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:1pt;margin-left:0pt;visibility:hidden;">​</span></p>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2354317
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4847429
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2022Q4 thm Capitalized Costs Mineral Properties
CapitalizedCostsMineralProperties
55375124
us-gaap Acquisition Costs
AcquisitionCosts
0
CY2023Q3 thm Capitalized Costs Mineral Properties
CapitalizedCostsMineralProperties
55375124
thm Aircraft Services Costs
AircraftServicesCosts
13200
thm Aircraft Services Costs
AircraftServicesCosts
9000
thm Environmental Costs
EnvironmentalCosts
151023
thm Environmental Costs
EnvironmentalCosts
156412
thm Equipment Rental
EquipmentRental
42835
thm Equipment Rental
EquipmentRental
51365
thm Mining Activities Field Costs
MiningActivitiesFieldCosts
74601
thm Mining Activities Field Costs
MiningActivitiesFieldCosts
74030
thm Geological And Geophysical Costs
GeologicalAndGeophysicalCosts
49202
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
547925
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
449572
thm Legal Fee Expense Income
LegalFeeExpenseIncome
48128
thm Legal Fee Expense Income
LegalFeeExpenseIncome
78653
thm Transportation And Traveling Cost
TransportationAndTravelingCost
15410
thm Transportation And Traveling Cost
TransportationAndTravelingCost
-7685
us-gaap Costs Incurred Exploration Costs
CostsIncurredExplorationCosts
893122
us-gaap Costs Incurred Exploration Costs
CostsIncurredExplorationCosts
860549
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
115796
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
104198
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39101
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
130648
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
154897
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
234846
CY2023Q3 thm Accrued General Corporate Cost Current
AccruedGeneralCorporateCostCurrent
98835
CY2023Q3 thm Accrued Project Cost Current
AccruedProjectCostCurrent
16961
CY2022Q4 thm Accrued General Corporate Cost Current
AccruedGeneralCorporateCostCurrent
46974
CY2022Q4 thm Accrued Project Cost Current
AccruedProjectCostCurrent
57224
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195313184
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195885531
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M12D
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1787049
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1547049
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2287049
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2047049
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
240000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
240000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
240000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.67
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
240000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.48
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
65096
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2023Q3 thm Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesAuthorized
0.10
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
401360
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
427834
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
320762
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2554567
CY2023Q3 us-gaap Assets
Assets
57937156
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
55375124
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7465
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5000001
CY2022Q4 us-gaap Assets
Assets
60382590
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-710351
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-295260
us-gaap Net Income Loss
NetIncomeLoss
-2681785
us-gaap Net Income Loss
NetIncomeLoss
-2209512
CY2023Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
206215
CY2023Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
747539
CY2023Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
753306
CY2023Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
759145
CY2023Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
765057
CY2023Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
771043
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
4002305

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001410578-23-002231-index-headers.html Edgar Link pending
0001410578-23-002231-index.html Edgar Link pending
0001410578-23-002231.txt Edgar Link pending
0001410578-23-002231-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thm-20230930.xsd Edgar Link pending
thm-20230930x10q.htm Edgar Link pending
thm-20230930x10q001.jpg Edgar Link pending
thm-20230930xex31d1.htm Edgar Link pending
thm-20230930xex31d2.htm Edgar Link pending
thm-20230930xex32d1.htm Edgar Link pending
thm-20230930xex32d2.htm Edgar Link pending
thm-20230930_cal.xml Edgar Link unprocessable
thm-20230930_lab.xml Edgar Link unprocessable
thm-20230930_def.xml Edgar Link unprocessable
thm-20230930_pre.xml Edgar Link unprocessable
thm-20230930x10q_htm.xml Edgar Link completed